GATA2 deficiency is one of the most common genetic predispositions to myelodysplastic syndrome (MDS), accounting for 7% of all pediatric patients diagnosed with MDS initially thought to be de novo (4). The gene discussed is GATA2; the disease is myelodysplastic syndrome.